Personalized Medicine: Its Role in Dementia
The purpose of this activity is to enable to learner to better understand the uses and implications of pharmacogenomics testing in older adults with dementia to best determine the most appropriate pharmacologic intervention.
Target Audience
Registered Nurses and other healthcare professionals who work with the older adults and perswons with dementia.
Learning Objectives
After this presentation the learner will be able to:
- Discuss the role of pharmacogenonimcs testing in persons with dementia
- Identify the difference between pharmacokinetic and pharmacodynamic mechanisms and their importance in use of psychotropic medications in the elderly
- Discuss possibilities for pharmacogenomic testing to improve clinical care and reduce health care costs in the older adult population
Dr. Allan Anderson
Director of Dementia Care Practice, Integrace
Assistant Professor of Psychiatry & Behavioral Sciences
the Johns Hopkins University School of Medicine.
Director of Dementia Care Practice, Integrace
Assistant Professor of Psychiatry & Behavioral Sciences
the Johns Hopkins University School of Medicine.
Available Credit
- 1.00 ANCC
- 1.00 Attendance